BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG (BIOCEUTICAL INNOVATIONS) BIOCEUTICAL INNOVATIONS From Erdal Can Alkoclar WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS,… Metadata quality: Metadata quality: Data description filled Files documented License filled Update frequency not followed File formats are closed Temporal coverage not set Spatial coverage not set All files are available Learn more about this indicator Metadata quality: 56.0% Updated on May 17, 2020 Creative Commons Attribution 4.0 0 reuses 0 favorites
An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections (NOVIR ) NOVIR From Mas Pharmaceuticals An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA… Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are closed Temporal coverage not set Spatial coverage not set All files are available Learn more about this indicator Metadata quality: 44.0% Updated on April 21, 2020 Creative Commons Attribution 4.0 0 reuses 0 favorites
